2-10 Review

Reviewing my operations from the beginning of the year until now:

1.$Unitedhealth(UNH.US) I got impatient and chased the high when UnitedHealth rose to 375, then panicked and used up all my bullets when it crashed to 300. Now I'm stuck with an overweight position at an average cost of 326. Next time I encounter a crash, I must plan properly and buy in batches using the pyramid method. Let this be a lesson!

2.$Meta Platforms(META.US) Thanks to my boss's earnest reminder, I managed to sell some at highs. Although it's now a mini position, my holding cost is very low. I'll just leave it for now.

3.$Taiwan Semiconductor(TSM.US) TSMC is also a mini position with a negative cost, making it the second stock after AMD where I have a negative cost basis. The volatility is a bit high. I might clear my AMD position later depending on the situation.

Overall, I'm currently deeply trapped in UnitedHealth. Given this trend, it will be difficult to return to my cost line anytime soon. Being unable to sell a portion means I'll miss other opportunities to add positions, like Microsoft. This highlights the importance of position management. The plan to sell AMD is also to concentrate my holdings for better management; being too scattered means I have no funds to rescue any position when they fall. Later, if I free up cash, I might buy some TLT$iShares barclays 20+ Yr Treasury Bd(TLT.US) or other defensive stocks. I haven't decided yet; I'll just buy whichever offers the best value for money.